Walleye Trading
OCUL icon

Walleye Trading’s Ocular Therapeutix OCUL Stock Holding History

Walleye Trading’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Buy
+29,000
New +$276K ﹤0.01% 2998
2022
Q1 		– Sell
-6,600
Closed -$46K – 5731
2021
Q4 		$46K Buy
+6,600
New +$51.3K ﹤0.01% 4700
2021
Q3 		– Sell
-11,800
Closed -$167K – 5554
2021
Q2 		$167K Buy
+11,800
New +$179K ﹤0.01% 4071

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Walleye Trading's OCUL Position: Q1 2026 in Review

Walleye Trading sold out of Ocular Therapeutix (OCUL) in Q1 2026, closing a stake of 18,165 shares — an estimated $173K sold.

Walleye Trading first reported a position in OCUL in Q4 2016 and held it in 8 quarters. The position peaked at $262K in Q1 2023. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Walleye Trading reported no remaining Ocular Therapeutix position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 18,165 Ocular Therapeutix shares in Q1 2026, an estimated $173K.
  • Walleye Trading first reported a position in Ocular Therapeutix in Q4 2016 and held it in 8 quarters.
  • Walleye Trading's Ocular Therapeutix position peaked at $262K in Q1 2023.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.